Cargando…
Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas
BACKGROUND: Ovarian cancer is the main cause of gynecological cancer-associated death. However, 5-year survival rates differ dramatically between the five main ovarian carcinoma histotypes. Therefore, we need to have a better understanding of the mechanisms that promote histotype-specific ovarian ca...
Autores principales: | Engqvist, Hanna, Parris, Toshima Z., Kovács, Anikó, Nemes, Szilárd, Werner Rönnerman, Elisabeth, De Lara, Shahin, Biermann, Jana, Sundfeldt, Karin, Karlsson, Per, Helou, Khalil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751742/ https://www.ncbi.nlm.nih.gov/pubmed/31533654 http://dx.doi.org/10.1186/s12885-019-6084-4 |
Ejemplares similares
-
Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes
por: Engqvist, Hanna, et al.
Publicado: (2020) -
Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry
por: Engqvist, Hanna, et al.
Publicado: (2020) -
Clonal relatedness in tumour pairs of breast cancer patients
por: Biermann, Jana, et al.
Publicado: (2018) -
Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma
por: Parris, Toshima Z., et al.
Publicado: (2018) -
Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival
por: Engqvist, Hanna, et al.
Publicado: (2018)